Stock NAMS FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Frazier Lifesciences Acquisition Corporation

Equities

NAMS

NL00150012L7

Real-time Estimate Tradegate
Other stock markets
 21:00:00 26/06/2024 BST 		5-day change 1st Jan Change
18.45 EUR -6.20% Intraday chart for Frazier Lifesciences Acquisition Corporation +14.96% +76.10%
06-11 NewAmsterdam Pharma Gets Another US Patent Extending IP Protection for Obicetrapib Until July 2043 MT
06-10 Transcript : NewAmsterdam Pharma Company N.V. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 10:40 AM
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Bio Therapeutic Drugs
+0.20%+14.96%+76.10%+61.23% - 1.77B - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. NAMS Stock
  4. Charts Frazier Lifesciences Acquisition Corporation
  5. Comparison Chart